Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control

Partial Agonists of the α3β4* Neuronal Nicotinic Acetylcholine Receptor Reduce Ethanol Consumption and Seeking in Rats

(2010) Susmita Chatterjee et al.   NEUROPSYCHOPHARMACOLOGY

Cognitive enhancement as a pharmacotherapy target for stimulant addiction

(2009) Mehmet Sofuoglu   ADDICTION

Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

(2009) Hans Rollema et al.   BIOCHEMICAL PHARMACOLOGY

Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers

(2009) Sherry A. McKee et al.   BIOLOGICAL PSYCHIATRY

The Smoking Cessation Medication Varenicline Attenuates Alcohol and Nicotine Interactions in the Rat Mesolimbic Dopamine System

(2009) M. Ericson et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

The influence of mecamylamine on ethanol and sucrose self-administration

(2009) Matthew M. Ford et al.   NEUROPHARMACOLOGY

The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats

(2009) Eoin C. O’Connor et al.   PSYCHOPHARMACOLOGY

Modulation of ethanol drinking-in-the-dark by mecamylamine and nicotinic acetylcholine receptor agonists in C57BL/6J mice

(2009) Linzy M. Hendrickson et al.   PSYCHOPHARMACOLOGY

Varenicline Improves Mood and Cognition During Smoking Abstinence

(2008) Freda Patterson et al.   BIOLOGICAL PSYCHIATRY

Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice

(2008) Danielle Gulick et al.   NEUROBIOLOGY OF LEARNING AND MEMORY

Impulsive Choice and Impulsive Action Predict Vulnerability to Distinct Stages of Nicotine Seeking in Rats

(2007) Leontien Diergaarde et al.   BIOLOGICAL PSYCHIATRY